{
    "organizations": [],
    "uuid": "ceb501cc1d5c962c4c79def55f5a7c3dd9297148",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-arrowhead-pharmaceuticals-presents/brief-arrowhead-pharmaceuticals-presents-preclinical-data-on-expanding-cardiometabolic-pipeline-idUSFWN1SI0OB",
    "ord_in_thread": 0,
    "title": "BRIEF-Arrowhead Pharmaceuticals Presents Preclinical Data On Expanding Cardiometabolic Pipeline",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 11 (Reuters) - Arrowhead Pharmaceuticals Inc:\n* ARROWHEAD PHARMACEUTICALS PRESENTS PRECLINICAL DATA ON EXPANDING CARDIOMETABOLIC PIPELINE\n* ARROWHEAD PHARMACEUTICALS - INTENDS TO FILE CLINICAL TRIAL APPLICATIONS FOR ARO-ANG3 & ARO-APOC3 BEFORE END OF 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-11T19:35:00.000+03:00",
    "crawled": "2018-05-12T17:24:15.018+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "arrowhead",
        "pharmaceutical",
        "inc",
        "arrowhead",
        "pharmaceutical",
        "present",
        "preclinical",
        "data",
        "expanding",
        "cardiometabolic",
        "pipeline",
        "arrowhead",
        "pharmaceutical",
        "intends",
        "file",
        "clinical",
        "trial",
        "application",
        "end",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}